Compound information
- Natural Products
- ZC488891
- Molecular Formula
- C17H21N5O2
- Molecular Weight
- 327.169524912 g/mol
- Structure
-
- IUPAC Name
- N-(6-methoxy-3-pyridyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C17H21N5O2/c1-24-16-5-4-15(12-19-16)20-17(23)22-9-7-21(8-10-22)13-14-3-2-6-18-11-14/h2-6,11-12H,7-10,13H2,1H3,(H,20,23)
- InChI Key
- RJWKBJDOVARPCI-UHFFFAOYSA-N
- SMILES
- COc1ccc(NC(=O)N2CCN(Cc3cccnc3)CC2)cn1
- Source
- ZINC000044950934
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 70.59 Å2 | LogP | 1.214 |
LogS | -1.732 | LogD | 1.955 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.126 | Pgp substrate | 0.933 |
HIA | 0.834 | F20 % | 0.934 |
F30 % | 0.692 | Caco-2 | -4.803 |
MDCK | -5.242 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.465 | PPB | 61.274 |
VD | 1.369 | Fu | 0.362 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.104 | CYP1A2 substrate | 0.739 |
CYP2A6 substrate | 0.733 | CYP2B6 substrate | 0.729 |
CYP2C19 inhibitor | 0.152 | CYP2C19 substrate | 0.756 |
CYP2C8 substrate | 0.808 | CYP2C9 inhibitor | 0.447 |
CYP2C9 substrate | 0.732 | CYP2D6 inhibitor | 0.616 |
CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.821 |
CYP3A4 inhibitor | 0.183 | CYP3A4 substrate | 0.989 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.796 | CL | 12.048 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.111 | Hepatotoxicity | 0.281 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.757 |
FDAMDD | 0.529 | Skin Sensitization | 0.904 |
Carcinogenicity | 0.17 | Eye Corrosion | 0.005 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.842 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.443 | IGC50 | 2.063 |
LC50FM | -3.615 | LC50DM | -5.206 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.274 | NR-AR-LBD | 0.213 |
NR-AhR | 0.64 | NR-Aromatase | 0.023 |
NR-ER | 0.368 | NR-ER-LBD | 0.298 |
NR-PPAR-gamma | 0.128 | SR-ARE | 0.744 |
SR-ATAD5 | 0.42 | SR-HSE | 0.112 |
SR-MMP | 0.013 | SR-p53 | 0.06 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.